China Pharma Holdings Files Q3 2024 10-Q
Ticker: CPHI · Form: 10-Q · Filed: Nov 13, 2024 · CIK: 1106644
| Field | Detail |
|---|---|
| Company | China Pharma Holdings, Inc. (CPHI) |
| Form Type | 10-Q |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
China Pharma Holdings filed its Q3 2024 10-Q on Nov 13, 2024. Check financials.
AI Summary
China Pharma Holdings, Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company, previously known as TS Electronics Inc. and Softstone Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations industry. The filing was made on November 13, 2024, under SEC file number 001-34471.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for China Pharma Holdings, Inc. for the third quarter of 2024.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures.
Key Players & Entities
- CHINA PHARMA HOLDINGS, INC. (company) — Registrant
- 001-34471 (company) — SEC File Number
- 20240930 (date) — Quarterly period end date
- 20241113 (date) — Filing date
- TS ELECTRONICS INC (company) — Former company name
- SOFTSTONE INC (company) — Former company name
FAQ
What is the SEC file number for China Pharma Holdings, Inc.?
The SEC file number for China Pharma Holdings, Inc. is 001-34471.
What period does this 10-Q report cover?
This 10-Q report covers the quarterly period ended September 30, 2024.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on November 13, 2024.
What industry does China Pharma Holdings, Inc. operate in?
China Pharma Holdings, Inc. operates in the Pharmaceutical Preparations industry, with SIC code 2834.
What were some of the former names of China Pharma Holdings, Inc.?
Some of the former names of China Pharma Holdings, Inc. include TS ELECTRONICS INC and SOFTSTONE INC.
Filing Stats: 4,438 words · 18 min read · ~15 pages · Grade level 18 · Accepted 2024-11-13 16:05:50
Key Financial Figures
- $0.001 — were 19,253,363 shares of common stock, $0.001 par value per share, issued and outstan
Filing Documents
- ea0220325-10q_chinaphar.htm (10-Q) — 646KB
- ea022032501ex31-1_china.htm (EX-31.1) — 10KB
- ea022032501ex31-2_china.htm (EX-31.2) — 10KB
- ea022032501ex32-1_china.htm (EX-32.1) — 5KB
- 0001213900-24-097461.txt ( ) — 4416KB
- cphi-20240930.xsd (EX-101.SCH) — 40KB
- cphi-20240930_cal.xml (EX-101.CAL) — 41KB
- cphi-20240930_def.xml (EX-101.DEF) — 222KB
- cphi-20240930_lab.xml (EX-101.LAB) — 401KB
- cphi-20240930_pre.xml (EX-101.PRE) — 239KB
- ea0220325-10q_chinaphar_htm.xml (XML) — 410KB
FINANCIAL INFORMATION
PART I FINANCIAL INFORMATION 1 Item 1.
Financial Statements
Financial Statements 1 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 31 Item 4.
Controls and Procedures
Controls and Procedures 31
OTHER INFORMATION
PART II OTHER INFORMATION 32 Item 6. Exhibits 32 i
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES TABLE OF CONTENTS Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 (Unaudited) 2 Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited) 3 Condensed Consolidated Statements of Stockholders' Equity for the Nine Months Ended September 30, 2024 and 2023 (Unaudited) 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023 (Unaudited) 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6 1 CHINA PHARMA HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (USD) (Unaudited) September 30, December 31, 2024 2023 ASSETS Current Assets: Cash and cash equivalents $ 718,691 $ 1,423,838 Banker's acceptances 26,943 65,915 Trade accounts receivable, less allowance for doubtful accounts of $ 13,935,643 and $ 13,786,074 , respectively 333,371 504,448 Other receivables, less allowance for doubtful accounts of $ 30,704 and $ 27,017 , respectively 46,553 157,944 Advances to suppliers 366 2,013 Inventories 2,498,851 3,732,517 Prepaid expenses 114,202 110,258 Total Current Assets 3,738,977 5,996,933 Property, plant and equipment, net 5,305,709 7,100,425 Right-of-use assets 58,931 116,610 Intangible assets, net 4,361,993 3,255,232 TOTAL ASSETS $ 13,465,610 $ 16,469,200 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Trade accounts payable $ 390,239 $ 966,420 Accrued expenses 82,613 298,829 Other payables 1,678,718 2,282,692 Advances from customers 24,920 90,507 Borrowings from related parties 1,166,294 1,133,809 Lease liabilities 60,241 77,727 Current portion of lines of credit 1,041,756 1,030,680 Convertible, redeemable note payable, net of issue discount 315,428 940,000 Total Current Liabiliti